<DOC>
	<DOCNO>NCT01090752</DOCNO>
	<brief_summary>This study examine effect pioglitazone renal sodium handle subject prone insulin resistance , i.e . diabetic and/or hypertensive subject .</brief_summary>
	<brief_title>Renal Hormonal Effects Pioglitazone</brief_title>
	<detailed_description>Aim : Glitazones powerful insulin sensitizer prescribe treatment type 2 diabetes . Their use however associate fluid retention increase risk congestive heart failure . We previously demonstrate pioglitazone increase proximal sodium reabsorption healthy volunteer . This study examine effect pioglitazone renal sodium handle subject prone insulin resistance , i.e . diabetic and/or hypertensive subject . Methods : In double-blind , randomize , placebo-controlled , four-way , cross-over study , examine effect pioglitazone ( 45mg daily 6 week ) placebo renal , systemic hormonal response change sodium intake 16 individual , 8 type 2 diabetic 8 hypertension .</detailed_description>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type II Diabetes Hypertension Cardiac renal disease Anaemia Drugs like aspirin , non steroidal antiinflammatory drug hormonal replacement therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>diabetes</keyword>
	<keyword>blood pressure</keyword>
	<keyword>pioglitazone</keyword>
	<keyword>sodium</keyword>
	<keyword>insulin resistance , renal function , sodium , pioglitazone</keyword>
</DOC>